{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:24:24Z","timestamp":1794230664915,"version":"4.9.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005242","name":"Universit\u00e9 de Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Research Fund Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Informatics"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ijmedinf.2026.106763","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:56:10Z","timestamp":1791993370000},"page":"106763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Factors influencing the institutionalization of digital pharmacovigilance tools in LMICs: a scoping review using the non-adoption, abandonment, scale-up, spread, and sustainability framework"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9880-650X","authenticated-orcid":false,"given":"Racha","family":"Soubra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Lehoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassane","family":"Alami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangaman Christian","family":"Akani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soutongnoma Safiata","family":"Kabore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0005","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-022-01071-5","article-title":"How public health crises expose systemic, day-to-day health inequalities in low- and-middle income countries: an example from East Africa","volume":"11","author":"Davis","year":"2022","journal-title":"Antimicrob Resist Infect Control."},{"issue":"10258","key":"10.1016\/j.ijmedinf.2026.106763_b0010","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"The Lancet."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0015","first-page":"4","article-title":"Barriers and facilitators for the sustainability of digital health interventions in low and middle-income countries: a systematic review","author":"Kabor\u00e9","year":"2022","journal-title":"Front Digit Health. Frontiers Media S.A."},{"issue":"9","key":"10.1016\/j.ijmedinf.2026.106763_b0020","article-title":"Implementation strategies for health systems in low-income countries: an overview of systematic reviews","volume":"2017","author":"Pantoja","year":"2017","journal-title":"Cochrane Database System Rev. John Wiley and Sons Ltd."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13031-023-00560-7","article-title":"Health systems resilience in fragile and conflict-affected settings: a systematic scoping review","volume":"18","author":"Truppa","year":"2024","journal-title":"Confl Health."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0030","volume":"19","author":"Sameri","year":"2025","journal-title":"Adaptive Health Systems: Innovations in Crisis Management During Armed Conflicts. Disaster Med Public Health Prep"},{"key":"10.1016\/j.ijmedinf.2026.106763_b0035","article-title":"Adverse drug reaction reporting by healthcare providers in sub-Saharan Africa: A scoping review of the challenges faced and the strategies to address the challenges","volume":"19","author":"Moyo","year":"2023","journal-title":"Int J Afr Nurs Sci. Elsevier Ltd."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0040","doi-asserted-by":"crossref","unstructured":"El-Jardali F, Bou-Karroum L, Jabbour M, et al. Digital health in fragile states in the Middle East and North Africa (MENA) region: A scoping review of the literature. PLoS One. 2023;18(4 APRIL). doi:10.1371\/journal.pone.0285226.","DOI":"10.1371\/journal.pone.0285226"},{"key":"10.1016\/j.ijmedinf.2026.106763_b0045","first-page":"3","article-title":"Reflections on family medicine and primary healthcare in sub- Saharan Africa","author":"Mash","year":"2018","journal-title":"BMJ Glob Health. BMJ Publishing Group."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1213\/ANE.0000000000004846","article-title":"The COVID-19 pandemic: effects on low- and middle-income countries","volume":"131","author":"Bong","year":"2020","journal-title":"Anesth Analg."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0055","unstructured":"WHO. The Importance of Pharmacovigilance. World Health Organization\u202f: Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring; 2002."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0060","first-page":"15","article-title":"The crucial role of pharmacovigilance in managing infectious diseases in lower and middle-income countries","author":"Khan","year":"2024","journal-title":"Ther Adv Drug Saf. SAGE Publications Ltd."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0065","first-page":"717","volume":"56","author":"Garashi","year":"2022","journal-title":"A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators. Ther Innov Regul Sci"},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.30574\/wjbphs.2025.21.1.0027","article-title":"Rethinking pharmacovigilance: Building inclusive drug safety systems for marginalized populations","volume":"21","author":"Jain","year":"2025","journal-title":"World J Biol Pharmacy Health Sci"},{"key":"10.1016\/j.ijmedinf.2026.106763_b0075","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.53730\/ijhs.v6nS5.11201","article-title":"Pharmacovigilance: significance and challenges","author":"Brahmbhatt","year":"2022","journal-title":"Int J Health Sci (Qassim)"},{"issue":"4","key":"10.1016\/j.ijmedinf.2026.106763_b0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/17512433.2015.1053391","article-title":"Pharmacovigilance in resource-limited countries","volume":"8","author":"Olsson","year":"2015","journal-title":"Expert Rev Clin Pharmacol. Expert Reviews Ltd."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0085","doi-asserted-by":"crossref","unstructured":"Dubale AT, Tareke AA, Butta FW, et al. Healthcare professionals\u2019 willingness to utilize a mobile health application for adverse drug reaction reporting in a limited resource setting: An input for digital health, 2023. Eur J Obstet Gynecol Reprod Biol X. 2024;23. doi:10.1016\/j.eurox.2024.100324.","DOI":"10.1016\/j.eurox.2024.100324"},{"issue":"6","key":"10.1016\/j.ijmedinf.2026.106763_b0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jbspin.2006.09.002","article-title":"Pharmacovigilance forevaluating adverse drug reactions: value, organization, andmethods","volume":"73","author":"Montastruc","year":"2006","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0095","unstructured":"Brewer T, Colditz GA. Postmarketing Surveillance and Adverse Drug Reactions Current Perspectives and Future Needs. www.fda.gov\/medwatch."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0100","doi-asserted-by":"crossref","unstructured":"Hazell L, Shakir SAW. Under-Reporting of Adverse Drug Reactions A Systematic Review. Vol 29. 2006.","DOI":"10.2165\/00002018-200629050-00003"},{"key":"10.1016\/j.ijmedinf.2026.106763_b0105","doi-asserted-by":"crossref","unstructured":"Kiguba R, Olsson S, Waitt C. Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa. Br J Clin Pharmacol. John Wiley and Sons Inc. 2023;89(2):491-509. doi:10.1111\/bcp.15193.","DOI":"10.1111\/bcp.15193"},{"issue":"7","key":"10.1016\/j.ijmedinf.2026.106763_b0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40264-023-01302-7","article-title":"Factors associated with underreporting of adverse drug reactions by health care professionals: a systematic review update","volume":"46","author":"Garc\u00eda-Abeijon","year":"2023","journal-title":"Drug Saf. Adis."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0115","doi-asserted-by":"crossref","unstructured":"Mekonnen AB, Alhawassi TM, McLachlan AJ, Brien J anne E. Adverse Drug Events and Medication Errors in African Hospitals: A Systematic Review. Drugs Real World Outcomes. Springer International Publishing. 2018;5(1). doi:10.1007\/s40801-017-0125-6.","DOI":"10.1007\/s40801-017-0125-6"},{"key":"10.1016\/j.ijmedinf.2026.106763_b0120","unstructured":"Tantray J. Pharmacovigilance: a meta-analysis on ADRS of Past and Recent Tragedy Occurred in Gambia. Published online 2023. doi:10.35248\/2329-6887.23.11.409."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0125","doi-asserted-by":"crossref","unstructured":"Lavertu A, Vora B, Giacomini KM, Altman R, Rensi S. A New Era in Pharmacovigilance: Toward Real-World Data and Digital Monitoring. Clin Pharmacol Ther. John Wiley and Sons Inc. 2021;109(5):1197-1202. doi:10.1002\/cpt.2172.","DOI":"10.1002\/cpt.2172"},{"key":"10.1016\/j.ijmedinf.2026.106763_b0130","doi-asserted-by":"crossref","DOI":"10.1177\/20420986241300006","article-title":"Pharmacovigilance processes in low- and middle-income countries: moving from data collection to data analysis and interpretation","volume":"16","author":"Menang","year":"2025","journal-title":"Ther Adv Drug Saf."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12911-022-01832-7","article-title":"Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience","volume":"22","author":"Fukushima","year":"2022","journal-title":"BMC Med Inform Decis Mak."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0140","article-title":"Opportunities for implementing digital applications to monitor the impact of risk-minimization measures within the pharmacovigilance process: scoping review of published literature","volume":"72","author":"Getov","year":"2025","journal-title":"Pharmacia. Pensoft Publishers."},{"issue":"5","key":"10.1016\/j.ijmedinf.2026.106763_b0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40264-022-01170-7","article-title":"Artificial intelligence-based pharmacovigilance in the setting of limited resources","volume":"45","author":"Liang","year":"2022","journal-title":"Drug Saf. Adis."},{"issue":"11","key":"10.1016\/j.ijmedinf.2026.106763_b0150","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.8775","article-title":"Beyond adoption: A new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up, spread, and sustainability of health and care technologies","volume":"19","author":"Greenhalgh","year":"2017","journal-title":"J Med Internet Res."},{"issue":"6","key":"10.1016\/j.ijmedinf.2026.106763_b0155","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/jamia\/ocx102","article-title":"Barriers to the success of an electronic pharmacovigilance reporting system in Kenya: An evaluation three years post implementation","volume":"25","author":"Agoro","year":"2018","journal-title":"J Am Med Inf Assoc"},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0160","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-022-13867-6","article-title":"Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa","volume":"22","author":"Stegmann","year":"2022","journal-title":"BMC Public Health."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0165","doi-asserted-by":"crossref","unstructured":"Scott WR. Institutional Theory: Contributing to a Theoretical Research Program. 2004.","DOI":"10.1093\/oso\/9780199276813.003.0022"},{"key":"10.1016\/j.ijmedinf.2026.106763_b0170","doi-asserted-by":"crossref","unstructured":"Vamadevan A, Vijayan V, Cole C, Jayasudha K, Yusuf N, Walker LE. A NASSS framework-guided systematic review and exploratory modelling of digital health interventions for polypharmacy management in older adults. BMC Geriatr. Published online November 22, 2025. doi:10.1186\/s12877-025-06602-4.","DOI":"10.1186\/s12877-025-06602-4"},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0175","article-title":"Identifying barriers and facilitators to successful implementation of computerized clinical decision support systems in hospitals: a NASSS framework-informed scoping review","volume":"18","author":"Abell","year":"2023","journal-title":"Implement Sci BioMed Central Ltd."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0180","doi-asserted-by":"crossref","unstructured":"Warmoth K, Lynch J, Darlington N, Bunn F, Goodman C. Using video consultation technology between care homes and health and social care professionals: a scoping review and interview study during COVID-19 pandemic. Age Ageing. Oxford University Press. 2022;51(2). doi:10.1093\/ageing\/afab279.","DOI":"10.1093\/ageing\/afab279"},{"key":"10.1016\/j.ijmedinf.2026.106763_b0185","doi-asserted-by":"crossref","unstructured":"James HM, Papoutsi C, Wherton J, Greenhalgh T, Shaw SE. Spread, Scale-up, and sustainability of video consulting in health care: systematic review and synthesis guided by the NASSS framework. J Med Internet Res. JMIR Publications Inc. 2021;23(1). doi:10.2196\/23775.","DOI":"10.2196\/23775"},{"key":"10.1016\/j.ijmedinf.2026.106763_b0190","doi-asserted-by":"crossref","unstructured":"Valdes D, Hijazi G, Shanker A, et al. Global Evidence on the sustainability of telemedicine in outpatient and primary care during the first two years of the COVID-19 pandemic: a scoping review using the NASSS framework. (Preprint). Interact J Med Res. Published online December 27, 2022. doi:10.2196\/45367.","DOI":"10.2196\/45367"},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol: Theory Practice"},{"issue":"10","key":"10.1016\/j.ijmedinf.2026.106763_b0200","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"7","key":"10.1016\/j.ijmedinf.2026.106763_b0205","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med Am College Phys"},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2024-001464","article-title":"Barriers and strategies to improve vaccine adverse events reporting: views from health workers and managers in Northern Ghana","volume":"3","author":"Ansah","year":"2025","journal-title":"BMJ Public Health."},{"issue":"6","key":"10.1016\/j.ijmedinf.2026.106763_b0215","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40264-023-01303-6","article-title":"Facilitators and barriers to uptake of the med safety mobile app for adverse drug reaction reporting by health workers in Uganda: a qualitative study","volume":"46","author":"Kiguba","year":"2023","journal-title":"Drug Saf."},{"issue":"8 August","key":"10.1016\/j.ijmedinf.2026.106763_b0220","article-title":"Perception of healthcare administrators on the impediments of optimizing adverse events following immunization e-Reporting in Nigeria","volume":"20","author":"Erekosima","year":"2025","journal-title":"PLoS One."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0225","doi-asserted-by":"crossref","DOI":"10.1177\/2042098619871190","article-title":"Factors that influence the intention to use mobile phone caller tunes for patient reporting of adverse drug reactions: a qualitative study","volume":"10","author":"Appiah","year":"2019","journal-title":"Ther Adv Drug Saf."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0230","unstructured":"Akel M, Ramia E, Hajj A. Medication Safety Spontaneous Reporting System: The Lebanese Order of Pharmacists Initiative. Published online 2019. doi:10.1016\/j.bfopcu.2019.02.001."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0235","first-page":"9","article-title":"First results from the lessons learnt from the deployment of the Med Safety App for reporting adverse drug reactions in Ghana","author":"Seaneke","year":"2023","journal-title":"Digit Health."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jphs.12330","article-title":"Consumer reporting of suspected adverse drug reactions: modelling the acceptance of mobile phone caller tunes to raise awareness","volume":"11","author":"Appiah","year":"2020","journal-title":"J Pharm Health Serv Res"},{"issue":"2","key":"10.1016\/j.ijmedinf.2026.106763_b0245","doi-asserted-by":"crossref","DOI":"10.2196\/publichealth.4605","article-title":"Texting-based reporting of adverse drug reactions to ensure patient safety: a feasibility study","volume":"1","author":"Vergeire-Dalmacion","year":"2015","journal-title":"JMIR Public Health Surveill."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12553-020-00510-w","article-title":"Use of mobile phones for patient self-reporting adverse drug reactions: A pilot study at a tertiary hospital in Rwanda","volume":"11","author":"Kadima","year":"2021","journal-title":"Health Technol (Berl)."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0255","first-page":"63","article-title":"Implementation of smartphone application for reporting adverse events following immunization by the treating doctors in tertiary care teaching hospitals in Chennai, India: Pilot and feasibility study","author":"Krishnamurthy","year":"2025","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0260","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-015-0932-8","article-title":"Feasibility and cost of using mobile phones for capturing drug safety information in peri-urban settlement in Ghana: a prospective cohort study of patients with uncomplicated malaria","volume":"14","author":"Kukula","year":"2015","journal-title":"Malar J."},{"issue":"5","key":"10.1016\/j.ijmedinf.2026.106763_b0265","doi-asserted-by":"crossref","DOI":"10.2196\/mhealth.6261","article-title":"Mobile app design, development, and publication for adverse drug reaction assessments of causality, severity, and preventability","volume":"5","author":"Ithnin","year":"2017","journal-title":"JMIR Mhealth Uhealth."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0270","doi-asserted-by":"crossref","unstructured":"Adedeji-Adenola H, Nlooto M. Development of an Interventional Tool for Direct Reporting of Adverse Drug Reactions by Healthcare Users in South Africa. Vol 24. 2021. www.ajbrui.org.","DOI":"10.1007\/s11096-020-01141-x"},{"issue":"8","key":"10.1016\/j.ijmedinf.2026.106763_b0275","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40267-024-01078-5","article-title":"Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso","volume":"40","author":"Ouoba","year":"2024","journal-title":"Drugs and Therapy Perspectives."},{"issue":"10","key":"10.1016\/j.ijmedinf.2026.106763_b0280","doi-asserted-by":"crossref","first-page":"e1761","DOI":"10.1016\/S2214-109X(25)00299-2","article-title":"Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trial","volume":"13","author":"Kiguba","year":"2025","journal-title":"Lancet Glob Health."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0285","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-82474-9","article-title":"Effectiveness of the modified TaWai mobile application for reporting adverse drug reaction in Lao PDR: a cluster randomized controlled trial","volume":"14","author":"Mongkhonmath","year":"2024","journal-title":"Sci Rep."},{"issue":"45","key":"10.1016\/j.ijmedinf.2026.106763_b0290","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1016\/j.vaccine.2023.09.037","article-title":"Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial","volume":"41","author":"Nyambayo","year":"2023","journal-title":"Vaccine."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0295","unstructured":"Geraldine Elemuwa U, Bitrus F, Adekunle Oreagba I, et al. Trends in adverse event reporting before and after the introduction of the medsafety app in nigeria running title: reporting trends using the med safety app. www.nafdac.gov.ng."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0300","first-page":"178","article-title":"Implementation of a pharmacovigilance system in a resources-limited country in the context of COVID-19: Lebanon\u2019s success story","volume":"57","author":"Abbas","year":"2023"},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0305","article-title":"Systematic review and meta-analysis on effectiveness of strategies for enhancing adverse drug reaction reporting","volume":"65","author":"Mongkhonmath","year":"2025","journal-title":"J. Am. Pharmacists Assoc."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0310","unstructured":"WHO. The Global Smart Pharmacovigilance Strategy. 2025."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0315","unstructured":"WHO. Tools and innovations in PV. Published online 2025."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0320","unstructured":"UMC. Uppsala Reports \u2013 Strengthening pharmacovigilance systems in resource-limited countries. Uppsala Reports. Published online 2023."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0325","series-title":"Impact Assessment: Regulation and Prequalification Activities External Assessment Report on Programmes in the Department of","author":"Rpq","year":"2023"},{"key":"10.1016\/j.ijmedinf.2026.106763_b0330","unstructured":"WHO. Regulation and Prequalification. https:\/\/www.who.int\/teams\/regulation-prequalification\/regulation-and-safety\/pharmacovigilance."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0335","unstructured":"WHO. Unmasking Safety Signals during a Pandemic Virtual Meeting-6 December 2021. 2022."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0340","unstructured":"WHO. WHO Global Benchmarking Tool (GBT) for Evaluation of National Regulatory System of Medical Products. 2021."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0345","article-title":"Effectiveness of mobile applications in enhancing adverse drug reaction reporting: a systematic review","volume":"3","author":"Liyanage","year":"2025","journal-title":"BMC Digital Health."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0350","unstructured":"WHO. Strengthening Health Systems To Improve Health Outcomes. World Health Organization; 2007."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0355","unstructured":"WHO. WHO Pharmacovigilance Indicators: A Practical Manual For The Assessment Of Pharmacovigilance Systems. 2015."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0360","unstructured":"WHO. Establishing Surveillance Systems In Countries Using Covid-19 Vaccines Safety Surveillance Manual. 2020."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0365","unstructured":"WHO. Ebola disease caused by Bundibugyo virus - Democratic Republic of the Congo. Published online 2026."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0370","unstructured":"WHO. Guidelines on the Quality, Safety and Efficacy of Ebola Vaccines. 2018."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0375","doi-asserted-by":"crossref","unstructured":"Tuohy CH, Glied S. The Political Economy of Health Care. In The Oxford Handbook of Health Economics . 2011.","DOI":"10.1093\/oxfordhb\/9780199238828.001.0001"},{"key":"10.1016\/j.ijmedinf.2026.106763_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.115272","article-title":"The politics of public health investments","volume":"309","author":"Jacques","year":"2022","journal-title":"Soc Sci Med."},{"issue":"9","key":"10.1016\/j.ijmedinf.2026.106763_b0385","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071079","article-title":"Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review","volume":"13","author":"Menang","year":"2023","journal-title":"BMJ Open."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0390","article-title":"Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration","volume":"16","author":"Nagar","year":"2025","journal-title":"Ther. Adv Drug Saf SAGE Publications Ltd."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0395","doi-asserted-by":"crossref","DOI":"10.1177\/20420986251342941","article-title":"Building functional and sustainable pharmacovigilance systems: an analysis of pharmacovigilance development across high-, middle- and low-income countries","volume":"16","author":"Menang","year":"2025","journal-title":"Ther. Adv Drug Saf."},{"issue":"8","key":"10.1016\/j.ijmedinf.2026.106763_b0400","article-title":"Strengthening regulatory systems globally: a crucial step towards pandemic preparedness and response","volume":"8","author":"Mukherjee","year":"2023","journal-title":"BMJ Glob Health. BMJ Publishing Group"},{"issue":"12","key":"10.1016\/j.ijmedinf.2026.106763_b0405","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s40264-023-01363-8","article-title":"The role of ISoP in the advancement of pharmacovigilance in low-and middle-income countries (LMICs)","volume":"46","author":"Elhawary","year":"2023","journal-title":"Drug Saf. Adis."},{"key":"10.1016\/j.ijmedinf.2026.106763_b0410","doi-asserted-by":"crossref","DOI":"10.1177\/20420986231188836","article-title":"Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries","volume":"14","author":"Isah","year":"2023","journal-title":"Ther. Adv. Drug Saf."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0415","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5530\/ijper.58.1s.2","article-title":"Role of social media for drug safety signal detection","volume":"58","author":"Sulakhiya","year":"2024","journal-title":"Indian J. Pharm. Educat. Res. Assoc. Pharm. Teachers India"},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0420","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-024-11112-x","article-title":"Understanding the integration of artificial intelligence in healthcare organisations and systems through the NASSS framework: a qualitative study in a leading Canadian academic centre","volume":"24","author":"Alami","year":"2024","journal-title":"BMC Health Serv Res."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0425","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1108\/JHOM-03-2020-0074","article-title":"Organizational readiness for artificial intelligence in health care: insights for decision-making and practice","volume":"35","author":"Alami","year":"2021","journal-title":"J Health Organ Manag."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106763_b0430","article-title":"Health system strengthening in fragile and conflict-affected states: a call to action","volume":"21","author":"Landry","year":"2021","journal-title":"BMC Health Serv Res. BioMed Central Ltd."}],"container-title":["International Journal of Medical Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386505626005034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386505626005034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T12:27:45Z","timestamp":1794227265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386505626005034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":86,"alternative-id":["S1386505626005034"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmedinf.2026.106763","relation":{},"ISSN":["1386-5056"],"issn-type":[{"value":"1386-5056","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors influencing the institutionalization of digital pharmacovigilance tools in LMICs: a scoping review using the non-adoption, abandonment, scale-up, spread, and sustainability framework","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmedinf.2026.106763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106763"}}